The Korean Journal of Internal Medicine

Search

Close

Original Article
Korean J Med. 2010;78(4):503-506.
Sunitinib 치료 이후 발생한 갑상선중독증 1예
이호영, 김미경, 김남경, 김혜순, 류성열, 권기영, 박근규
A case of thyrotoxicosis after sunitinib treatment
Ho Young Lee, Mi Kyung Kim, Nam Keong Kim, Hye Soon Kim, Seong-Yeol Ryu, Ki Young Kwon, Keun Gyu Park


Abstract
Sunitinib is a tyrosine-kinase inhibitor used to treat metastatic renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors. Hypothyroidism is a common side effect of sunitinib therapy. Nevertheless, overt thyrotoxicosis induced by destructive thyroiditis after sunitinib treatment is very rare. Here, we report a patient with overt thyrotoxicosis related to sunitinib therapy.

Keywords :Sunitinib, Thyrotoxicosis
hanmi ckdpharm. AMGEN
Memo patch yungjin daewoongbio

Go to Top